News - Keryx Biopharmaceuticals, perifosine

Filter

Popular Filters

AEterna Zentaris and Keryx shares tank as cancer drug flops in Ph III

03-04-2012

Canadian drug developer AEterna Zentaris (TSX: AEZ) and US licensee Keryx Pharmaceutical (Nasdaq: KERX)…

AEterna ZentarisKeryx BiopharmaceuticalsLicensingNephrology and HepatologyOncologyperifosinePharmaceuticalResearchZerenex

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top